BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8647203)

  • 41. Characterization of TNF receptors on human thymocytes.
    Murphy M; Pike-Nobile L; Soo VW; Epstein LB
    Thymus; 1994-1995; 23(3-4):177-94. PubMed ID: 8525504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
    Sivori S; Cantoni C; Parolini S; Marcenaro E; Conte R; Moretta L; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3439-47. PubMed ID: 14635054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes.
    Carlyle JR; Zúñiga-Pflücker JC
    J Immunol; 1998 Dec; 161(12):6544-51. PubMed ID: 9862680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and function of CD2 during murine thymocyte ontogeny.
    Yagita H; Asakawa J; Tansyo S; Nakamura T; Habu S; Okumura K
    Eur J Immunol; 1989 Dec; 19(12):2211-7. PubMed ID: 2575032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirements for growth of immature thymocytes from fetal and adult mice in vitro.
    Palacios R; Von Boehmer H
    Eur J Immunol; 1986 Jan; 16(1):12-9. PubMed ID: 3081352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
    J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a novel CD2+ human thymic B cell subset.
    Punnonen J; de Vries JE
    J Immunol; 1993 Jul; 151(1):100-10. PubMed ID: 7686927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic and functional maturation of TCR gammadelta cells in the human thymus.
    Offner F; Van Beneden K; Debacker V; Vanhecke D; Vandekerckhove B; Plum J; Leclercq G
    J Immunol; 1997 May; 158(10):4634-41. PubMed ID: 9144475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
    Poggi A; Pardi R; Pella N; Morelli L; Sivori S; Vitale M; Revello V; Moretta A; Moretta L
    Eur J Immunol; 1993 Oct; 23(10):2454-63. PubMed ID: 8405045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein.
    Altevogt P; Kohl U; Von Hoegen P; Lang E; Schirrmacher V
    Eur J Immunol; 1989 Feb; 19(2):341-6. PubMed ID: 2564824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation.
    Poggi A; Costa P; Tomasello E; Moretta L
    Eur J Immunol; 1998 May; 28(5):1611-6. PubMed ID: 9603467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of a natural killer clone upon target cell binding via CD2.
    Nakamura T; Takahashi K; Koyanagi M; Yagita H; Okumura K
    Eur J Immunol; 1991 Mar; 21(3):831-4. PubMed ID: 1672650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
    Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
    J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigen-independent pathways of T-cell activation are functional in human immature thymocytes.
    Poggi A; Zocchi MR
    Int J Clin Lab Res; 1992; 21(4):304-9. PubMed ID: 1375518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human natural killer cell committed thymocytes and their relation to the T cell lineage.
    Sánchez MJ; Spits H; Lanier LL; Phillips JH
    J Exp Med; 1993 Dec; 178(6):1857-66. PubMed ID: 7504051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD1+ thymocytes proliferate and give rise to functional cells after stimulation with monoclonal antibodies recognizing CD3, CD2 or CD28 surface molecules.
    Zocchi MR; Marelli F; Poggi A
    Cell Immunol; 1990 Sep; 129(2):394-403. PubMed ID: 1696526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NKRP1A molecule is involved in transendothelial migration of CD4+ human T lymphocytes.
    Poggi A; Costa P; Zocchi MR; Moretta L
    Immunol Lett; 1997 Jun; 57(1-3):121-3. PubMed ID: 9232437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I.
    Maguer-Satta V; Gazzolo L; Dodon MD
    Blood; 1995 Aug; 86(4):1444-52. PubMed ID: 7632951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
    Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
    Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody.
    Ogasawara J; Suda T; Nagata S
    J Exp Med; 1995 Feb; 181(2):485-91. PubMed ID: 7530758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.